Product Browser

Last updated: 2017/8/13

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

ANXA1 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00000301-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-ANXA1 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 38.17
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-ANXA1 antibody (H00000301-B01) by Western Blots.
    Western Blot
    QC Testing of H00000301-T01
    Lane 1: ANXA1 transfected lysate ( 38.7 KDa)
    Lane 2: Non-transfected lysate.
    SDS-PAGE Gel
    QC Testing of H00000301-T01
    ANXA1 transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 301
  • Gene Name:
  • ANXA1
  • Gene Alias:
  • ANX1,LPC1
  • Gene Description:
  • annexin A1
  • Gene Summary:
  • Annexin I belongs to a family of Ca(2+)-dependent phospholipid binding proteins which have a molecular weight of approximately 35,000 to 40,000 and are preferentially located on the cytosolic face of the plasma membrane. Annexin I protein has an apparent relative molecular mass of 40 kDa, with phospholipase A2 inhibitory activity. Since phospholipase A2 is required for the biosynthesis of the potent mediators of inflammation, prostaglandins and leukotrienes, annexin I may have potential anti-inflammatory activity. [provided by RefSeq
  • Other Designations:
  • OTTHUMP00000021474,OTTHUMP00000021475,annexin I,annexin I (lipocortin I),lipocortin I
  • RSS
  • YouTube
  • Linkedin
  • Facebook